Pirfenidone treatment in idiopathic pulmonary fibrosis: nationwide Danish results

Pirfenidone was approved by the European Medicines Agency and introduced in most European countries in 2011 for treatment of idiopathic pulmonary fibrosis (IPF). To describe the national Danish experiences of pirfenidone treatment for IPF during 30 months with respect to target population, safety, a...

Full description

Saved in:
Bibliographic Details
Published inEuropean clinical respiratory journal Vol. 3; no. 1; p. 32608
Main Authors Salih, Goran Nadir, Shaker, Saher Burhan, Madsen, Helle Dall, Bendstrup, Elisabeth
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 2016
Co-Action Publishing
Taylor & Francis Group
Subjects
Online AccessGet full text

Cover

Loading…